Skip to main content
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
About us
Our science
Our Pipeline
Partnering
News & Events
Contact
In the news
Press releases
Archive
Oct 25, 2023
Galimedix Appoints Dr. Luciana Summo as Vice President, R&D Operations
Mar 29, 2023
Théa Open Innovation and Galimedix announce strategic partnership to develop and commercialize GAL-101, a Phase 2/3-ready small molecule, to treat ophthalmic indications with high unmet medical need
Jun 15, 2021
Galimedix Accelerating Development of Its Next-Generation Oral Anti-Amyloid Beta Drug GAL-201 for Alzheimer’s Disease
Upcoming Events
7th Annual NeuroScience Innovation Forum
January 7, 2024
42nd Annual JP Morgan Healthcare Conference
January 8-11, 2024
AD/PD™ 2024: Advances in science and therapy
March 5-9, 2024
